Triveritas provides comprehensive product development, clinical study and regulatory affairs services to the animal health industry with offices in UK, USA, Canada, Germany and France.
Triveritas joins Cyton Biosciences as part of the knoell group
Share / follow:
Since the year 2000 the company has expanded from 3 to over 30 staff operating in the UK, USA, Canada, Germany, France and Poland.
Triveritas’ growth can be attributed to commitment, knowledge,
expertise and flexibility.
Projects are tailored to match individual client needs particularly in the areas of animal GCP trials, regulatory affairs,
project management and Quality Assurance.
Concept to marketing approval
At Triveritas strategic regulatory advice goes hand in hand with effective project planning and expertise across all development areas to steer a product through the vital development stages as swiftly and efficiently as possible.